Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

Lancet

Volumn 352, Issue 9137, 1998, Pages 1347-1351

  Forette, Françoise ^a   Seux, Marie Laure ^a   Staessen, Jan A ^b   Thijs, Lutgarde ^b   Birkenhäger, Willem H ^c   Babarskiene, Marija Ruta ^d   Babeanu, Speranta ^e   Bossini, Alfredo ^f   Gil Extremera, Blas ^g   Girerd, Xavier ^h   Laks, Tovio ⁱ   Lilov, Emil ^j   Moisseyev, Valentine ^k   Tuomilehto, Jaakko ^l   Vanhanen, Hannu ^m   Webster, John ⁿ   Yodfat, Yair ^o   Fagard, Robert ^b  

^a Paris Descartes University   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d Institute of Cardiology   (Lithuania)

^e Gerontology and Geriatrics   (Romania)

^f Ctro Ipertensione Policlin U   (Italy)

^g UNIVERSITY OF GRANADA   (Spain)

^h HÔPITAL BROUSSAIS   (France)

ⁱ WEST TALLINN CENTRAL HOSPITAL   (Estonia)

^j Regional Health Center   (Bulgaria)

^k Moscow Clinical Hospital   (Russian Federation)

^l NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^m HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁿ UNIVERSITY OF ABERDEEN   (United Kingdom)

^o HEBREW UNIVERSITY OF JERUSALEM   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; NITRENDIPINE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR DISORDERS; DEMENTIA, VASCULAR; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; HYPERTENSION; INTELLIGENCE TESTS; MALE; MIDDLE AGED; RISK FACTORS; SYSTOLE;

EID: 0032564132     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03086-4     Document Type: Article

References (27)

1. 1 Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-54.
2. 2 Forette F, Boller F. Hypertension and risk of dementia in the elderly. Am J Med 1991; 90: 14S-19S.
3. 3 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
4. 4 Amery A, Birkenhäger W, Bulpitt CJ, et al. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging Clin Exp Res 1991; 3: 287-302.
5. 5 Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64 (correction: Lancet 1997; 350: 1636).
6. 6 Forette F, Amery A, Staessen J, et al. Is prevention of vascular dementia possible? The Syst-Eur Vascular Dementia Project. Aging Clin Exp Res 1991; 3: 373-82.
7. 7 Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
8. 8 Folstein MF, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc 1985; 33: 228-35.
9. 9 Gagnon M, Letenneur L, Dartigues JF, et al. The validity of the Mini Mental State Examination as screening instrument for cognitive impairment and dementia in French elderly community residents. Neuroepidemiology 1990; 3: 143-50.
10. 10 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn, revised. Washington DC, American Psychiatric Association, 1987.
11. 11 Letenneur L, Commenges RD, Dartigues JF, Barberger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol 1994; 23: 1256-61.
12. 12 Launer JL. Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology 1992; 11 (suppl 1): 2-13.
13. 13 Ott A, Breteler MMB, van Harskamp F, Grobbee DE, Hofman A. The incidence of dementia in the Rotterdam study. In: Iqbal K, Winblad B, Nishimura T, Takeda K, Winieski H, eds. Alzheimer's disease: biology, diagnosis and therapeutics. New York: John Wiley, 1997: 1-10.
14. 14 Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983; 14: 399-401.
15. 15 Hachinski VC, Lliff LD, Zilkha E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-37.
16. 16 Rogers RL, Meyer JS, Mortel K. Decreased cerebral blood flow precedes multi-infarct dementia but follows senile dementia of Alzheimer type. Neurology 1986; 36: 1-6.
17. 17 Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990; 300: 230-30.
18. 18 Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473-80.
19. 19 Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINCDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
20. 20 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC: American Psychiatric Association, 1994.
21. 21 Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337: 1667-74.
22. 22 Heckbert SR, Longstreth Jr WT, Psaty BM, et al. The association of antihypertensive agents with MRI white matter findings and the Modified Mini-Mental State Examination in older patients. J Am Geriatr Soc 1997; 45: 1423-33.
23. 23 Morich FJ, Bieber F, Lewis JM, et al. Nimodipine in the treatment of probable Alzheimer's disease: results of two multicentre trials. Clin Drug Invest 1996; 11: 185-95.
24. 24 Thompson LT, Moyer Jr JR, Black J, Disterhoft JF. Cellular mechanisms for nimodipine's reduction of aging related learning deficits. In: Meyer EM, Simpkins JW, Yamamoto J, Crews FT, eds. Treatment of dementias: a new generation of progress. New York: Plenum Press, 1992: 241-56.
25. 25 Parneti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs 1997; 53: 752-68.
26. 26 Hong YL. The relationship between calcium antagonist-induced hypotension and central monoaminergic system in spontaneously hypertensive rats. Int J Clin Pharmacol Ther Toxicol 1987; 11: 589-97.
27. 27 Gould RJ, Murphy KM, Snyder SH. Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]nitrendipine. Brain Res 1985; 330: 217-23.